M&T Bank
MRNA icon

M&T Bank’s Moderna MRNA Stock Holding History

M&T Bank’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.57M Buy
36,733
+7,454
+25% +$386K 0.01% 571
2026
Q1 		$1.49M Buy
29,279
+4,321
+17% +$202K ﹤0.01% 717
2025
Q4 		$736K Buy
24,958
+6,660
+36% +$181K ﹤0.01% 971
2025
Q3 		$473K Buy
18,298
+111
+0.6% +$3.1K ﹤0.01% 1007
2025
Q2 		$502K Sell
18,187
-821
-4% -$21.6K ﹤0.01% 1079
2025
Q1 		$539K Buy
19,008
+1,249
+7% +$44.3K ﹤0.01% 1035
2024
Q4 		$739K Buy
17,759
+1,622
+10% +$77.5K ﹤0.01% 1009
2024
Q3 		$1.08M Sell
16,137
-4,793
-23% -$440K ﹤0.01% 878
2024
Q2 		$2.49M Buy
20,930
+4,957
+31% +$627K 0.01% 583
2024
Q1 		$1.7M Buy
15,973
+613
+4% +$61.8K 0.01% 712
2023
Q4 		$1.53M Sell
15,360
-12,059
-44% -$1.01M 0.01% 734
2023
Q3 		$2.83M Buy
27,419
+1,046
+4% +$117K 0.01% 510
2023
Q2 		$3.2M Sell
26,373
-1,415
-5% -$189K 0.01% 508
2023
Q1 		$4.27M Sell
27,788
-3,650
-12% -$602K 0.02% 448
2022
Q4 		$5.65M Sell
31,438
-1,892
-6% -$309K 0.02% 398
2022
Q3 		$3.94M Sell
33,330
-342
-1% -$51.9K 0.02% 434
2022
Q2 		$4.61M Buy
33,672
+14,777
+78% +$2.11M 0.02% 379
2022
Q1 		$3.25M Buy
18,895
+3,537
+23% +$595K 0.01% 444
2021
Q4 		$3.9M Buy
15,358
+573
+4% +$168K 0.02% 430
2021
Q3 		$5.69M Buy
14,785
+744
+5% +$274K 0.03% 349
2021
Q2 		$3.3M Buy
14,041
+1,338
+11% +$239K 0.01% 457
2021
Q1 		$1.66M Sell
12,703
-637
-5% -$92.3K 0.01% 610
2020
Q4 		$1.39M Buy
13,340
+881
+7% +$89.1K 0.01% 670
2020
Q3 		$881K Buy
12,459
+1,725
+16% +$120K ﹤0.01% 750
2020
Q2 		$688K Buy
10,734
+3,688
+52% +$202K ﹤0.01% 818
2020
Q1 		$211K Buy
+7,046
New +$162K ﹤0.01% 1305

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

M&T Bank's MRNA Position: Q2 2026 in Review

M&T Bank increased its Moderna (MRNA) stake by 25% in Q2 2026, buying an estimated $386K and bringing the position to 36,733 shares worth $2.57M. The position accounts for 0.01% of the portfolio, ranked #571.

M&T Bank first reported a position in MRNA in Q1 2020 and has held it in 26 quarters since. The position peaked at $5.69M in Q3 2021. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • M&T Bank held 36,733 shares of Moderna worth $2.57M as of Q2 2026.
  • M&T Bank bought 7,454 Moderna shares in Q2 2026, an estimated $386K.
  • Moderna made up 0.01% of M&T Bank's portfolio in Q2 2026, its #571 holding.
  • M&T Bank first reported a position in Moderna in Q1 2020 and has held it in 26 quarters since.
  • M&T Bank's Moderna position peaked at $5.69M in Q3 2021.
  • 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.